Disclaimer

The Netherlands Pharmacovigilance Centre Lareb retains the copyright of the information on the website. None of the texts and reports shown on the site may be used, published, distributed and/or copied without written permission from Lareb. Using the information for personal purposes is allowed. Citing information on the website is allowed with Lareb as the source.

The Netherlands Pharmacovigilance Centre Lareb reserves the right to modify any information provided on the website at any time without notice.

This website contains links to websites or web pages of third parties. Lareb has no control over the content or other characteristics of these sites and is in no way liable or responsible for their content.

The information on this website is carefully composed. Nevertheless Lareb cannot accept liability for possible damage that might result from the use of the information on this site or the temporary inability to access the website. The use of the information is the personal responsibility of the user. The information is not intended as a substitute for medical care. Care for patients remains the responsibility of the care provider. Patients are advised, when in doubt about medications, health or possible treatment, always to contact your pharmacist, doctor or specialist. Never adjust the use of your prescribed medication without consulting your healthcare professional! Always discuss your symptoms with your physician or pharmacist, who knows your personal situation, knows what other medicines you use and can advise you what to do.

The reports shown on the website are only intended to give insight into the reported adverse drug reactions at the Netherlands Pharmacovigilance Centre Lareb. It does not always mean that there is a causal relation between the condition and the reported drug. It means the reporter suspects that the drug may be involved in the condition of the user of the drug.

Some drugs are used on a much larger scale than others. Of course, not all actually occurred adverse drug reactions are reported. The number of reports say nothing about the possibility of experiencing adverse drug reactions and it is not possible to calculate incidence rates based on the number of reports.